Stock listing
Frankfurt:H1Z NeuroSense Therapeutics Ltd. Aktie
German listing (Frankfurt) of NeuroSense Therapeutics Ltd. · home listing NASDAQ:NRSN
Follow NeuroSense Therapeutics Ltd. into a list and get an email when it puts out news.
Home listing price · NASDAQ:NRSN
$1.28 USD -0.15 (-10.5%)
Close on Nov 3, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:NRSN
- Day range
- $1.20 – $1.46 USDNov 3, 2026
- Volume
- 25,037 sharesNov 3, 2026
- Market cap
- $2.43M USDAt the close on Nov 3, 2026 · price × 1.90M shares outstanding
- 52-week range
- $1.10 – $25.40 USDLowest and highest trades, Nov 4, 2025 – Nov 3, 2026
- Traded on an average day
- $67,237 USDMedian day 8,820 shares · last 3 months, Aug 3, 2026 – Nov 3, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:NRSN · Home | $1.28 USD | -0.15 (-10.5%) | 25,037 | $1.40 | $1.46 | $1.20 | $1.43 | Close on Nov 3, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 3, 2026 · NASDAQ:NRSN · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.28 | -0.15 | -10.5% | $1.40 | $1.46 | $1.20 | 25,037 | |
| $1.43 | -0.56 | -28.1% | $2.02 | $2.04 | $1.10 | 407,490 | |
| $1.99 | -0.14 | -6.6% | $2.20 | $2.22 | $1.99 | 20,177 | |
| $2.13 | -0.23 | -9.7% | $2.302 | $2.32 | $2.09 | 20,577 | |
| $2.36 | -0.01 | -0.4% | $2.33 | $2.37 | $2.20 | 17,300 | |
| $2.37 | +0.04 | +1.7% | $2.30 | $2.60 | $2.28 | 22,274 | |
| $2.33 | -0.13 | -5.3% | $2.466 | $2.75 | $2.31 | 29,709 | |
| $2.46 | +0.02 | +0.8% | $2.49 | $2.55 | $2.40 | 11,153 | |
| $2.44 | -0.12 | -4.7% | $2.55 | $2.57 | $2.15 | 18,597 | |
| $2.56 | +0.17 | +7.1% | $2.46 | $2.70 | $2.41 | 11,257 | |
| $2.39 | -0.275 | -10.3% | $2.74 | $2.74 | $2.19 | 13,847 | |
| $2.665 | -0.405 | -13.2% | $2.94 | $2.94 | $2.359 | 117,602 | |
| $3.07 | -0.10 | -3.2% | $3.06 | $3.24 | $3.06 | 9,704 | |
| $3.17 | +0.11 | +3.6% | $3.08 | $3.261 | $2.87 | 11,863 | |
| $3.06 | -0.43 | -12.3% | $3.56 | $3.60 | $3.05 | 30,844 | |
| $3.49 | +0.01 | +0.3% | $3.774 | $3.784 | $3.365 | 43,216 | |
| $3.48 | -0.18 | -4.9% | $3.66 | $3.66 | $3.28 | 7,424 | |
| $3.66 | +0.08 | +2.2% | $3.614 | $3.85 | $3.614 | 15,607 | |
| $3.58 | -0.24 | -6.3% | $3.82 | $3.898 | $3.561 | 15,850 | |
| $3.82 | -0.25 | -6.1% | $3.95 | $4.07 | $3.79 | 12,891 | |
| $4.07 | +0.04 | +1.0% | $4.03 | $4.33 | $3.94 | 17,784 | |
| $4.03 | +0.095 | +2.4% | $4.06 | $4.54 | $3.96 | 12,245 | |
| $3.935 | -0.115 | -2.8% | $3.97 | $4.01 | $3.82 | 24,230 | |
| $4.05 | -0.38 | -8.6% | $4.37 | $4.37 | $3.827 | 51,913 | |
| $4.43 | -0.35 | -7.3% | $4.71 | $4.743 | $4.00 | 40,386 | |
| $4.78 | -0.32 | -6.3% | $5.04 | $5.54 | $4.355 | 35,864 | |
| $5.10 | -1.85 | -26.6% | $6.91 | $7.15 | $4.925 | 61,785 | |
| $6.95 | -0.45 | -6.1% | $7.18 | $7.18 | $6.733 | 8,674 | |
| $7.40 | 0.00 | 0.0% | $7.20 | $7.40 | $6.925 | 8,879 | |
| $7.40 | +0.22 | +3.1% | $7.35 | $7.40 | $6.80 | 8,761 | |
| $7.18 | +0.56 | +8.5% | $6.70 | $7.41 | $6.70 | 28,550 | |
| $6.62 | +0.27 | +4.3% | $6.42 | $6.85 | $6.40 | 6,385 | |
| $6.35 | -0.37 | -5.5% | $6.99 | $6.99 | $6.35 | 7,377 | |
| $6.72 | +0.23 | +3.5% | $6.35 | $6.95 | $6.30 | 13,680 | |
| $6.49 | -0.54 | -7.7% | $7.04 | $7.50 | $6.02 | 24,763 | |
| $7.03 | +0.13 | +1.9% | $6.43 | $7.29 | $6.055 | 42,311 | |
| $6.90 | -0.06 | -0.9% | $6.80 | $7.46 | $5.60 | 31,299 | |
| $6.96 | +0.32 | +4.8% | $6.92 | $7.00 | $6.60 | 569 | |
| $6.64 | -1.40 | -17.4% | $7.60 | $7.76 | $6.64 | 1,721 | |
| $8.04 | -0.32 | -3.8% | $8.64 | $9.00 | $7.96 | 850 | |
| $8.36 | -1.88 | -18.4% | $10.20 | $10.36 | $7.20 | 2,558 | |
| $10.24 | +2.20 | +27.4% | $8.00 | $10.52 | $7.20 | 10,561 | |
| $8.04 | -0.20 | -2.4% | $9.00 | $9.00 | $8.00 | 211 | |
| $8.24 | -0.16 | -1.9% | $8.36 | $9.00 | $7.80 | 530 | |
| $8.40 | -0.16 | -1.9% | $8.68 | $9.00 | $8.20 | 198 | |
| $8.56 | +0.16 | +1.9% | $9.00 | $9.00 | $8.12 | 418 | |
| $8.40 | -0.40 | -4.5% | $8.80 | $9.00 | $8.40 | 238 | |
| $8.80 | +0.60 | +7.3% | $8.04 | $8.80 | $8.00 | 147 | |
| $8.20 | +0.56 | +7.3% | $8.20 | $8.80 | $7.80 | 510 | |
| $7.64 | +0.12 | +1.6% | $7.80 | $8.40 | $7.40 | 478 | |
| $7.52 | 0.00 | 0.0% | $7.60 | $7.60 | $7.24 | 406 | |
| $7.52 | +0.52 | +7.4% | $7.28 | $7.80 | $7.04 | 321 | |
| $7.00 | -0.96 | -12.1% | $8.00 | $8.00 | $6.96 | 851 | |
| $7.96 | +0.32 | +4.2% | $8.00 | $10.00 | $5.00 | 3,640 | |
| $7.64 | -1.00 | -11.6% | $8.64 | $8.64 | $7.64 | 829 | |
| $8.64 | -0.44 | -4.8% | $9.68 | $10.20 | $8.52 | 1,111 | |
| $9.08 | +0.20 | +2.3% | $8.80 | $9.24 | $8.76 | 138 | |
| $8.88 | -0.52 | -5.5% | $9.40 | $9.64 | $8.84 | 632 | |
| $9.40 | -0.08 | -0.8% | $9.20 | $10.00 | $8.64 | 388 | |
| $9.48 | -0.20 | -2.1% | $10.00 | $10.20 | $9.12 | 360 | |
| $9.68 | -0.32 | -3.2% | $10.00 | $10.60 | $9.60 | 763 | |
| $10.00 | -0.08 | -0.8% | $10.00 | $10.60 | $9.44 | 244 | |
| $10.08 | -0.76 | -7.0% | $10.92 | $11.56 | $9.72 | 587 | |
| $10.84 | +0.44 | +4.2% | $10.20 | $12.00 | $10.20 | 735 | |
| $10.40 | +1.04 | +11.1% | $9.16 | $10.40 | $8.80 | 379 | |
| $9.36 | +0.04 | +0.4% | $7.88 | $10.00 | $7.88 | 1,130 |
- Ticker
- Frankfurt:H1Z
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Nov 2, 2026
NeuroSense to Strengthen PrimeC Canadian ALS Submission With New NfL Data
Latest deck · July 2026
Investor Presentation (July 2026)
Investor deck · 32 slides
Latest news
NeuroSense to Strengthen PrimeC Canadian ALS Submission With New NfL Data
Nov 2, 2026
Closed $1.43 (-28.1%) on Nov 2, 2026
NeuroSense to Present Integrated Clinical and Biomarker Evidence Shaping PrimeC's Phase 3 Development at NEALS 2026
Oct 29, 2026
Closed $2.13 (-9.7%) on Oct 29, 2026
NeuroSense Files U.S. Patent Application for Traumatic Brain Injury
Oct 19, 2026
Closed $2.67 (-13.2%) on Oct 19, 2026
NeuroSense Secures Nasdaq Hearing Date as PrimeC Approaches Key Regulatory and Funding Milestones
Oct 13, 2026
Closed $3.49 (+0.3%) on Oct 13, 2026
NeuroSense Provides Update on Nasdaq Listing Compliance
Oct 2, 2026
Closed $4.03 (+2.4%) on Oct 5, 2026
NeuroSense to Participate in the 5th Annual ROTH Healthcare Opportunities Conference
Sep 28, 2026
Closed $5.10 (-26.6%) on Sep 28, 2026
NeuroSense Provides Business Update and Progress for the First Half of 2026
Sep 25, 2026
Closed $5.10 (-26.6%) on Sep 28, 2026
NeuroSense to Present at H.C. Wainwright 28th Annual Global Investment Conference
Sep 10, 2026
Closed $6.64 (-17.4%) on Sep 10, 2026
NeuroSense Unveils Accelerated, Capital-Efficient Strategy to Advance PrimeC Toward Potential Approval in ALS
Aug 31, 2026
Closed $8.56 (+1.9%) on Aug 31, 2026
NeuroSense Issues CEO Letter to Shareholders
Aug 13, 2026
Closed $8.88 (-5.5%) on Aug 13, 2026
Decks
Investor Presentation (July 2026)
Investor deck · 32 slides · July 2026
Investor Presentation (April 2024)
Investor deck · 42 slides · Apr 10, 2024
Investor Presentation (February 2024)
Investor deck · 40 slides · Feb 22, 2024
Investor Presentation (January 2024)
Investor deck · 33 slides · Jan 9, 2024
NeuroSense Therapeutics Ltd. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 36 in the last 12 months · 137 in all · newest Nov 2, 2026 · oldest 2021
- Decks
- 18 decks · latest July 2026
Where NeuroSense Therapeutics Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:NRSN · Home listing | NASDAQ | United States | USD |
| BOATS:NRSN | BOATS | United States | USD |
| Frankfurt:H1Z · This page | Frankfurt | Germany | EUR |
Log in to ask 6ix AI your own questions about NeuroSense Therapeutics Ltd.